Host: |
Goat |
Applications: |
Pep-ELISA/WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-CLMP (C-Term) is suitable for use in ELISA and Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:4000.WB: Approx 50kDa band observed in Human Placenta lysates (calculated MW of 41.3kDa according to NP_079045.1). The observed molecular weight corresponds to earlier findings in literature wit |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
CLMP |
Gene ID: |
79827 |
Uniprot ID: |
CLMP_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_079045.1 |
Immunogen Sequence: |
PSMIPSQSRAFQ |
Function | May be involved in the cell-cell adhesion. May play a role in adipocyte differentiation and development of obesity. Is required for normal small intestine development. |
Protein Name | Cxadr-Like Membrane ProteinAdipocyte Adhesion MoleculeCoxsackie- And Adenovirus Receptor-Like Membrane ProteinCar-Like Membrane Protein |
Cellular Localisation | Cell JunctionTight JunctionCell MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Cxadr-Like Membrane Protein antibodyAnti-Adipocyte Adhesion Molecule antibodyAnti-Coxsackie- And Adenovirus Receptor-Like Membrane Protein antibodyAnti-Car-Like Membrane Protein antibodyAnti-CLMP antibodyAnti-ACAM antibodyAnti-ASAM antibodyAnti-UNQ318 antibodyAnti-PRO363 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance